One Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.4M | Buy |
19,720
+4,897
| +33% | +$2.57M | 0.36% | 71 |
|
|
2025
Q1 | $9.4M | Buy |
14,823
+2,337
| +19% | +$1.48M | 0.32% | 79 |
|
|
2024
Q4 | $8.89M | Buy |
12,486
+310
| +3% | +$221K | 0.29% | 88 |
|
|
2024
Q3 | $12.8M | Buy |
12,176
+508
| +4% | +$534K | 0.41% | 61 |
|
|
2024
Q2 | $12.3M | Buy |
11,668
+673
| +6% | +$707K | 0.42% | 56 |
|
|
2024
Q1 | $10.6M | Buy |
10,995
+25
| +0.2% | +$24.1K | 0.38% | 62 |
|
|
2023
Q4 | $9.63M | Sell |
10,970
-365
| -3% | -$321K | 0.38% | 63 |
|
|
2023
Q3 | $9.33M | Buy |
11,335
+480
| +4% | +$395K | 0.41% | 57 |
|
|
2023
Q2 | $7.8M | Buy |
10,855
+289
| +3% | +$208K | 0.35% | 68 |
|
|
2023
Q1 | $8.68M | Sell |
10,566
-56
| -0.5% | -$46K | 0.43% | 58 |
|
|
2022
Q4 | $7.66M | Sell |
10,622
-422
| -4% | -$304K | 0.41% | 66 |
|
|
2022
Q3 | $7.61M | Buy |
11,044
+487
| +5% | +$335K | 0.45% | 59 |
|
|
2022
Q2 | $6.24M | Buy |
10,557
+38
| +0.4% | +$22.5K | 0.37% | 71 |
|
|
2022
Q1 | $7.35M | Buy |
10,519
+144
| +1% | +$101K | 0.39% | 64 |
|
|
2021
Q4 | $6.55M | Sell |
10,375
-205
| -2% | -$129K | 0.5% | 50 |
|
|
2021
Q3 | $6.4M | Sell |
10,580
-643
| -6% | -$389K | 0.53% | 38 |
|
|
2021
Q2 | $6.27M | Buy |
11,223
+908
| +9% | +$507K | 0.56% | 41 |
|
|
2021
Q1 | $4.88M | Buy |
10,315
+1,251
| +14% | +$592K | 0.54% | 53 |
|
|
2020
Q4 | $4.38M | Buy |
9,064
+196
| +2% | +$94.7K | 0.53% | 55 |
|
|
2020
Q3 | $4.96M | Sell |
8,868
-177
| -2% | -$99.1K | 0.68% | 33 |
|
|
2020
Q2 | $5.64M | Sell |
9,045
-971
| -10% | -$606K | 0.81% | 28 |
|
|
2020
Q1 | $4.89M | Buy |
10,016
+811
| +9% | +$396K | 0.83% | 25 |
|
|
2019
Q4 | $3.46M | Buy |
+9,205
| New | +$3.46M | 0.53% | 48 |
|